Immunotherapy Is Not an Immunity Booster — The Difference That Matters

No. Immunotherapy is a regulated cancer treatment — usually a checkpoint inhibitor drug given by an oncologist, only after biomarker testing shows your specific cancer is likely to respond. An "immunity booster" is a marketing term for vitamins, herbal tonics, or IV drips that claim to raise immunity generally. No immunity booster is an approved cancer treatment.

The two words share a root idea — the immune system — and that overlap is exactly what gets exploited. "Immunotherapy" sounds close enough to "immunity booster" that a clinic brochure, a WhatsApp forward, or a well-meaning relative can blur the two without anyone intending harm. But one is prescribed against your cancer's specific biology; the other is sold to anyone, for a general feeling of wellness, and has never been tested as a cancer treatment.

"Boosting immunity" usually means a product — a vitamin, herbal tonic, IV drip, or injection — claims to make your immune system generally stronger. It targets no specific cancer, uses no biomarker test, and has no defined mechanism against tumour cells. Genuine immunotherapy does the opposite: it targets one specific molecular pathway, in patients selected by testing.

• What gets marketed as an "immunity booster" — vitamin C or glutathione IV drips, herbal or Ayurvedic immunity tonics, generic "immunity-boosting" injections at wellness clinics, and unverified supplements sold online.
• What genuine immunotherapy actually is — a checkpoint inhibitor or related drug that targets a specific pathway such as PD-1/PD-L1, prescribed only after your biomarker test confirms it's relevant, and given at an oncology day-care centre under medical monitoring.
• Who decides which one, if either, applies to you — your treating oncologist and tumour board, reviewing your cancer type, stage, and biomarker results — never a product label or a sales pitch.

This matters because most cancer patients in India are not automatic candidates for real immunotherapy — this is worth saying plainly. Eligibility depends on your exact cancer type and stage, biomarker results, and prior treatment. No "immunity booster" changes that eligibility in either direction, whatever a brochure claims.

If a treatment being offered to you doesn't fit the middle column, it is not immunotherapy — whatever it's called on the invoice.

Families searching for hope sometimes pay lakhs for "immunity-boosting" infusions or unproven injections, believing they are getting cancer immunotherapy. These products are rarely covered by insurance, are billed upfront in cash, and can delay a patient from starting an approved treatment that could actually help — the real cost is money and time.

Time matters especially: every week spent on an unproven product is a week not spent on a tumour board's actual plan. For some cancers, that delay changes what treatments remain realistic later. This is a patient-safety issue at least as much as a financial one.

1. 1

   Ask for the exact generic drug name

   "Immunotherapy" alone is not an answer — a genuine treatment has a specific generic drug name your oncologist can name and explain.

2. 2

   Ask which biomarker test result qualified you

   Real immunotherapy for a solid tumour is never given without a biomarker test behind it — if none was done, that's a red flag.

3. 3

   Confirm the doctor and the facility

   Check that the prescribing doctor is a registered oncologist and the facility is a recognised hospital or day-care cancer centre.

4. 4

   Ask for an itemised bill naming the drug

   A genuine treatment appears on a hospital bill with a named drug and dose — not as a lump-sum "immunity package."

5. 5

   Get a second opinion before paying

   If any answer above feels vague, rehearsed, or is refused, pause and get an independent second opinion before any payment is made.

• Vague terminology — "immunity boost," "natural cancer fighter," or "detox therapy" instead of a named drug or procedure.
• Upfront cash demanded — full payment before any written treatment plan or itemised bill is provided.
• No biomarker testing done — a claimed "immunotherapy" offered without any test to justify it.
• Guarantees of cure or "no side effects" — any promise this strong should prompt an immediate second opinion.
• Pressure to decide immediately — "today only," limited slots, or discouragement from consulting your existing oncologist.
• No documentation — no drug name, batch number, or prescription on record for what was actually infused or injected.

These are patterns to watch for in how a treatment is marketed, not an accusation against any specific clinic or practitioner.

If biomarker testing shows immunotherapy isn't an approved option for your cancer, that is a common, normal outcome — not a gap that an "immunity booster" can fill. Chemotherapy, surgery, radiation therapy, targeted therapy, or best supportive care remain well-evidenced options your tumour board will weigh carefully.

General wellness support — balanced nutrition, gentle exercise, adequate sleep, and psycho-oncology support — is genuinely useful alongside any treatment plan, and there's nothing wrong with wanting it. The distinction that matters is simple: support your treatment, discussed with your oncologist first; don't let it be sold to you as a replacement for one.

• Questions to Ask Before Starting Immunotherapy — the fuller list of questions to bring to your oncologist, beyond just verifying a claim.
• Getting a Second Opinion Before Starting Immunotherapy — how to arrange an independent review of any treatment plan or claim.
• Immunotherapy for Stage 4 Cancer: What It Can and Cannot Achieve — an honest look at realistic outcomes, for readers weighing a genuine immunotherapy plan.
• Immunotherapy at CION Cancer Clinics — the full picture of how CION supports patients through biomarker-guided, tumour-board-led immunotherapy.

This page is for general information and does not replace a consultation. Immunotherapy is administered as day care at CION centres; response-assessment PET-CT is coordinated at partner imaging centres. Only your oncologist, reviewing your complete case, can tell you whether immunotherapy applies to you.

Many families have asked exactly this question

Confusing marketing language for medical treatment is more common than you'd think. Our team will walk through any treatment claim with you, honestly and without pressure.